JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-8.09%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$62.5M
AUM Growth
+$62.5M
(-75%)
Cap. Flow
-$189M
Cap. Flow
% of AUM
-301.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
22
New
4
Increased
1
Reduced
5
Closed
12
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$43.3M |
| 2 |
SPDR S&P Pharmaceuticals ETF
XPH
|
$6.45M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$2.08M |
| 4 |
AB InBev
BUD
|
$1.92M |
| 5 |
Petrobras Class A
PBR.A
|
$1.15M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$183M |
| 2 |
Banco Macro
BMA
|
$20.8M |
| 3 |
VanEck Semiconductor ETF
SMH
|
$20.6M |
| 4 |
Kraft Heinz
KHC
|
$12.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$1.5M |
Sector Composition
| 1 | Consumer Staples | 9.89% |
| 2 | Healthcare | 3.76% |
| 3 | Energy | 3.33% |
| 4 | Financials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets ETF
EEM
$19B
| $43.3M | 69.36% |
+1,000,000
| New | +$43.3M |
|
|
2
SPDR S&P Pharmaceuticals ETF
XPH
$188M
| $6.45M | 10.33% |
+150,000
| New | +$6.45M |
|
|
3
AB InBev
BUD
$122B
| $6.18M | 9.89% |
61,313
+19,100
| +45% | +$1.92M |
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.08M | 3.33% |
+11,139
| New | +$2.08M |
|
|
5
Petrobras Class A
PBR.A
$73.9B
| $1.15M | 1.83% |
+129,578
| New | +$1.15M |
|
|
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.1M | 1.76% |
16,524
-5,810
| -26% | -$386K |
|
7
TechnipFMC
FTI
$15.1B
| $938K | 1.5% |
29,550
-20,600
| -41% | -$654K |
|
8
Incyte
INCY
$16.5B
| $739K | 1.18% |
11,025
-9,402
| -46% | -$630K |
|
9
Amicus Therapeutics
FOLD
$2.34B
| $292K | 0.47% |
18,691
-19,082
| -51% | -$298K |
|
10
Exelixis
EXEL
$10.1B
| $222K | 0.36% |
10,316
-11,704
| -53% | -$252K |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-12,273
| Closed | -$276K |
|
12
Assembly Biosciences
ASMB
$190M
| – | – |
-17,096
| Closed | -$840K |
|
|
13
Banco Macro
BMA
$3.7B
| – | – |
-192,736
| Closed | -$20.8M |
|
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-18,506
| Closed | -$1.5M |
|
15
Bristol-Myers Squibb
BMY
$96B
| – | – |
-10,340
| Closed | -$654K |
|
16
Boston Scientific
BSX
$156B
| – | – |
-15,302
| Closed | -$418K |
|
|
17
Kraft Heinz
KHC
$33.1B
| – | – |
-200,000
| Closed | -$12.2M |
|
|
18
VanEck Semiconductor ETF
SMH
$27B
| – | – |
-200,000
| Closed | -$20.6M |
|
|
19
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
-700,000
| Closed | -$183M |
|
|
AERI
20
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-13,844
| Closed | -$751K |
|
|
EPZM
21
DELISTED
Epizyme, Inc
EPZM
| – | – |
-15,333
| Closed | -$272K |
|
|
IMMU
22
DELISTED
Immunomedics Inc
IMMU
| – | – |
-15,474
| Closed | -$226K |
|